发明名称 |
New therapy for transthyretin-associated amyloidosis |
摘要 |
It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate. |
申请公布号 |
AU2012327275(A1) |
申请公布日期 |
2014.04.17 |
申请号 |
AU20120327275 |
申请日期 |
2012.10.23 |
申请人 |
SOM INNOVATION BIOTECH, S.L. |
发明人 |
CENTELLAS CASADO, MARC;INSA BORONAT, RAUL;REIG BOLANO, NURIA;GAVALDA BATALLA, NURIA |
分类号 |
A61K31/04;A61K31/275;A61P25/28 |
主分类号 |
A61K31/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|